Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 2 1

Status

Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Leukemia, Myeloid, Acute 25Myelodysplastic Syndromes 8Advanced Solid Tumors 8Myeloproliferative Disorders 5Leukemia, Myelomonocytic, Chronic 5Ovarian Neoplasms 4Neoplasms 4Multiple Myeloma 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Advanced Solid Tumour 4Advanced Solid Tumor 4Small Cell Lung Carcinoma 3Recurrence 3Leukemia, Monocytic, Acute 3Triple Negative Breast Neoplasms 2Thrombocythemia, Essential 2Squamous Cell Carcinoma of Head and Neck 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Neoplasm Metastasis 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Acute 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Biliary Tract Neoplasms 2Advanced Malignant Solid Tumor 2Advanced Lung Cancer 2

Interventions

tislelizumab 4pembrolizumab 4Injections 4toripalimab 3sotorasib 1serabelisib 1olaparib 1nedaplatin 1mirdametinib 1erdafitinib 1envafolimab 1darolutamide 1atezolizumab 1adagrasib 1abiraterone 1Taxes 1Nivolumab 1Magnetic Resonance Spectroscopy 1Fulvestrant 1Drug Therapy 1CD3 Complex 1Bevacizumab 1Antineoplastic Agents 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Advanced Solid Tumor × Injections × 90 days × Clear all
NCT05170958 2026-05-15

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Nanjing Leads Biolabs Co.,Ltd

Phase 1/2 Recruiting
396 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT05438329 2026-05-12

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

DualityBio Inc.

Phase 1/2 Active not recruiting
1,123 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06927687 2026-04-29

Study of ZG005 in Patients With Advanced Solid Tumors

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 2 Active not recruiting
50 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT07512583 2026-04-06

Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Not yet recruiting
178 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡